Medical groups question price of new hep C drug

WASHINGTON (AP) -- An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care experts, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences....

Read the whole article on AP Health

More from AP Health